AK146D1

· Akeso

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AK146D1, covering 2025-07-17 to 2025-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK146D1 for Injection in Advanced Solid Tumors [Phase 1]